Preventing Hair Loss from Cancer Chemotherapy
Richard B. Schwab, MD. Associate Clinical Professor of Medicine, Moores Cancer Center, University of California, San Diego, School of Medicine Q: Loss of hair is a predictable adverse effect of […]
Entries by melindaroberts
Mutational Oncology: The Basics
Vivian B. Douglas, PhD. Associate Knowledge Engineer, CollabRx San Francisco, California Q: Many mature clinicians find “Mutational Oncology” to be a bit mysterious. Please help them understand. As they pertain […]
The Most Relied Upon Journals in Precision Oncology
George Lundberg, MS, MD, ScD, MASCP, FCAP, Chief Medical Officer and Editor in Chief, CollabRx, a Rennova Health Company; Editor at Large, Medscape; Executive Adviser, Cureus; Consulting Professor of Pathology […]
Length and Quality of Life in Cancer Patient Treatment
Professor Michael Baum, Professor Emeritus of Surgery & Visiting Professor of Medical Humanities. University College, London, UK. Q: Although you have practiced as a surgeon in the British National Health […]
Canadian/American Cancer
Cynthia Martin, MA is a freelance/ghost writer (who tried to write a serious piece). Q: As a journalist, you are a savvy native Canadian consumer/patient who also knows a lot […]
Conflict of Interest in Cancer Clinical Trials
Kevin B. Knopf, MD MPH, Medical Director, Cancer Commons San Francisco, California Q: Clinical trials are the lifeblood of continuing drug development in the US. Yet they are often undersubscribed. […]
Can Preclinical Data Guide Clinical Cancer Therapy?
Keith Flaherty, MD, Associate Professor of Medicine, Harvard Medical School; Director of Developmental Therapeutics, Cancer Center, Massachusetts General Hospital. Q: Under what circumstances and to what extent are you willing […]
Circadian Cancer Therapy
William Hrushesky, MD FACP, Founder and Chief Scientific Officer Rythmalytics LLC (Cicada Circadian Coach), West Orange NJ; Chief Medical Officer Ambulatory Monitoring Inc., Ardsley, NY Q: Are there meaningful advantages […]
Generic Drugs vs. Biosimilar Biologics
Y. Tony Yang, ScD, LLM, MPH., Associate Professor, Department of Health Administration and Policy, George Mason University, Fairfax, Virginia. Charles Bennett, MD, PhD, M.P.P., Smart State and Frank P and Jose […]
Driver and Passenger Mutations in Cancer Cell Genes
Michelle Turski, PhD, Senior Scientific Knowledge Engineer, CollabRx Q: What are the similarities and differences between “driver” mutations and “passenger” mutations and in what common malignancies is that distinction most […]